Sunday, 26 September 2021

US firm Cue Health receives approval in India for point-of-care COVID-19 test

14 July 2021 | News

Cue Expands its Global Health Support Following International Authorizations in Canada and the European Union

Cue Health Inc., a healthcare technology company in the US, has announced it has received regulatory approval from The Central Drugs Standard Control Organisation (CDSCO) for the Cue COVID-19 Test for professional point-of-care use in India. Internationally, Cue has also received the CE mark in the European Union (EU), as well as Interim Order authorization from Health Canada.

Cue's easy-to-use, portable COVID-19 test provides highly accurate, lab-quality results – including detection of emerging variants – directly to connected mobile smart devices in about 20 minutes, and Cue's natively digital platform allows for end-to-end integrated reporting of test results.

Cue expects to enable end-to-end care journeys from diagnostic tests to physician consultation via telemedicine through intervention. The Cue Health Monitoring System is designed to deliver a broad menu of tests through one system. Cue plans to develop a suite of offerings to address respiratory health, sexual health, cardiac and metabolic health, women's health, men's health, and chronic disease management by connecting diagnostics with telemedicine.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account